Industry

Beijing Court Orders Liquidation of Zhongzhi Group and 316 Affiliates; Creditors Must File Claims by June 10

Beijing court orders substantive consolidation and liquidation of Zhongzhi Enterprise Group and 316 affiliates; creditors must file claims by June 10.

#china, #bankruptcy, #shadowbanking, #finance

Chevron Warns Accounting ‘Timing Effects’ and Working‑Capital Outflow Could Cut Billions From Q1 Results

On April 9, Chevron warned marking derivatives, LIFO inventory and a $2–4bn working‑capital outflow could trim roughly $2.7–$3.7bn from Q1 results.

#chevron, #oil, #earnings, #accounting, #energy

Maersk Keeps Ships on Longer Detours Despite Two‑Week Ceasefire for Strait of Hormuz

Maersk will keep vessels on longer detours despite a US‑Iran two‑week ceasefire that could allow limited, conditional transit through the Strait of Hormuz.

#maersk, #shipping, #straithormuz, #oil

Samsung Forecasts Record Quarterly Profit as AI Memory Chips Boom

Samsung projects a record Q1 2026 operating profit of about ₩57.2 trillion, driven largely by surging demand for AI memory chips.

#samsung, #semiconductors, #ai, #memory-chips

Neurocrine to Buy Soleno for $2.9 Billion, Picks Up Prader‑Willi Drug VYKAT XR

Neurocrine will acquire Soleno for $2.9B to add VYKAT XR, the newly approved Prader‑Willi hyperphagia drug, aiming to expand its rare‑disease portfolio.

#biotech, #m&a, #raredisease

Wipro Acquires Mindsprint from Olam in $375M Deal to Overhaul Agribusiness Tech

Wipro buys Olam's Mindsprint for $375M and signs $1B contract to transform agribusiness technology and shared services over eight years.

#wipro, #olam, #mindsprint, #agribusiness, #technology

Howmet Aerospace Finalizes $1.8 Billion Acquisition of Aerospace Fastening Maker CAM

Howmet Aerospace has acquired California-based CAM for $1.8 billion, expanding its aerospace fastener portfolio amid industry growth.

#aerospace, #acquisition, #howmet, #consolidatedaerospacemanufacturing, #fasteners

Biogen Signals $34 Million Deal-Related Charge as It Reshapes Earnings Strategy

Biogen warns of a $34M charge tied to licensing and research deals, underscoring the rising cost and volatility of its deal-driven strategy.

#biogen, #biotechnology, #earnings, #deal, #pharma

Colorado beef-plant strike pauses as 3,800 JBS workers vote to return while talks resume

After a three-week walkout at a major U.S. slaughterhouse, union workers at JBS’s Greeley, Colorado, plant return as negotiations restart.

#jbs, #meatpacking, #laborstrike, #beef

U.S. to repay TotalEnergies nearly $1 billion to drop offshore wind leases, redirecting investment to LNG and drilling

Interior will refund TotalEnergies’ 2022 offshore wind lease payments after it matches the sum in U.S. oil, gas and LNG investments.

#energy, #offshorewind, #lng, #oilgas, #interiordepartment

Charlotte’s Web to Swap Debt for Equity as British American Tobacco Becomes Top Shareholder

CBD pioneer Charlotte’s Web will erase long-term debt by converting BAT’s debenture to equity and raising $10M—diluting shareholders as BAT nears 41%.

#cbd, #hemp, #britishamericantobacco, #recapitalization, #medicare

Micron to Spend Over $4 Billion to Retire Long-Dated Bonds as AI Boom Boosts Cash Flow

Micron says investors tendered about 80% of $5.4B in notes in a cash buyback, paying up to an 8% premium as AI demand reshapes its finances.

#micron, #semiconductors, #ai, #bonds, #debt

GoHealth Reports 55% Revenue Drop and $498 Million Loss as Medicare Broker Pulls Back

GoHealth posted a steep 2025 revenue decline and a $498M loss after cutting Medicare Advantage enrollments, taking big impairments, and facing Nasdaq warnings.

#medicareadvantage, #insurance, #nasdaq, #earnings, #healthcare

MediaCo posts 40% revenue jump in 2025 as losses widen after EstrellaTV deal

Owner of Hot 97, WBLS and EstrellaTV reports $133.3M in 2025 revenue but a $66.2M loss, citing impairments, warrant swings and debt costs.

#broadcasting, #streaming, #earnings, #nasdaq, #multiculturalmedia

Oramed Sells Oral-Insulin Unit to Lifeward, Takes Major Stake in Exoskeleton Maker

Oramed sells its oral drug unit to Lifeward, receiving shares, warrants, royalties and convertible notes—positioning it as a near-control shareholder.

#biotech, #medtech, #nasdaq, #exoskeleton, #convertiblenotes